Yonsarx.com

Visit yonsarx.com
  • 2 weeks ago

    Last scanned

  • 8 years

    Domain Age

  • No data

    Daily Visitors

  • No data

    Global Rank

B9876A78-C14B-4F49-9F4B-396039336A47@1x

About Website

Updated:

Prescription Treatment for mCRPC | YONSA® (abiraterone acetate)

YONSA® is the first and only 500 mg dose of abiraterone acetate approved by the FDA, when used with methylprednisolone. The most common adverse drug reactions (≥10%) reported in the two randomized clinical trials that occurred more commonly (>

Yonsarx.com thumbnail
Yonsarx.com thumbnail

Trustworthy

99E6BC28-40D1-4264-B66E-CBC423C983BF@1x

Network Data

This website is hosted with Fastly, Inc., which reserves the following IP addresses for yonsarx.com: 146.75.35.10. Moreover, DNS used with this website include ns51.domaincontrol.com, ns52.domaincontrol.com.

  • 2 weeks ago

    Last scanned

  • 8 years

    Domain Age

  • No data

    Daily Visitors

  • No data

    Global Rank

Trustworthy

Network

ADDRESSING DETAILS

Whois

OWNERSHIP

  • Created

    2016-01-13

  • Expires

    2025-01-13

  • Owner

    Registration Private (Domains By Proxy, LLC)

  • Registar

    GODADDY.COM, LLC

Domain & Keywords

The registrar of yonsarx.com is GODADDY.COM, LLC and the name expires on 2025-01-13. Owner email is not available. Their country of residence is United States of America.

  • Abiraterone
  • prostate pills
  • micronization
  • metastatic prostate cancer
  • Abiraterone acetate
  • abiraterone cost
  • abiraterone side effects
  • yonsa
  • prostate cancer drugs
  • prostate cancer medication

Websites similar to yonsarx.com